Lates News

Amgen: Working with the US government to take action to lower the cost of drugs for American patients. Since 2018, Amgen has invested over $40 billion in manufacturing and research and development. It will expand its "direct-to-patient" program AmgenNow to include Aimovig and Amjevita. All three drugs will also be available through TRUMPRX.GOV. Aimovig and Amjevita will be offered at a discounted price of $299 per month.